Involvement of the δ-opioid receptor in exercise-induced cardioprotection

Experimental Physiology

Volumn 100, Issue 4, 2015, Pages 410-421

  Miller, Lindsey E ^a   Mcginnis, Graham R ^a   Peters, Bridget A ^a   Ballmann, Christopher G ^a   Nanayakkara, Gayani ^b   Amin, Rajesh ^b   Quindry, John C ^a  

^a AUBURN UNIVERSITY   (United States)

^b AUBURN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; ENDORPHIN; MESSENGER RNA; NALTRINDOLE; PROENKEPHALIN; ENKEPHALIN; PROTEIN PRECURSOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; HEART PROTECTION; IN VIVO STUDY; MALE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHAM PROCEDURE; SOLEUS MUSCLE; SPRAGUE DAWLEY RAT; TISSUE NECROSIS; TREADMILL EXERCISE; WESTERN BLOTTING; ANIMAL; FITNESS; HEART INFARCTION PREVENTION; HEART VENTRICLE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOPHYSIOLOGY; PROCEDURES; SKELETAL MUSCLE; TREATMENT OUTCOME;

ANIMALS; ENKEPHALINS; HEART VENTRICLES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MUSCLE, SKELETAL; MYOCARDIAL REPERFUSION INJURY; PHYSICAL CONDITIONING, ANIMAL; PHYSICAL FITNESS; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, DELTA; TREATMENT OUTCOME;

EID: 84925955113     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2014.083436     Document Type: Article

References (51)

1. Benito B, Gay-Jordi G, Serrano-Mollar A, Guasch E, Shi Y, Tardif JC, Brugada J, Nattel S & Mont L (2011). Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation 123, 13-22.
2. ATP channel in the rat. J Physiol 569, 913-924.
3. Brown DA, Jew KN, Sparagna GC, Musch TI & Moore RL (2003). Exercise training preserves coronary flow and reduces infarct size after ischemia-reperfusion in rat heart. J Appl Physiol 95, 2510-2518.
4. Brown DA, Johnson MS, Armstrong CJ, Lynch JM, Caruso NM, Ehlers LB, Fleshner M, Spencer RL & Moore RL (2007). Short-term treadmill running in the rat: what kind of stressor is it? J Appl Physiol 103, 1979-1985.
5. ATP channel blockade in the rat heart. Am J Physiol Heart Circ Physiol 292, H2432-H2437.
6. Collins HL, Loka AM & Dicarlo SE (2005). Daily exercise-induced cardioprotection is associated with changes in calcium regulatory proteins in hypertensive rats. Am J Physiol Heart Circ Physiol 288, H532-H540.
7. Crook TJ, Kitchen I & Hill RG (1992). Effects of the δ-opioid receptor antagonist naltrindole on antinociceptive responses to selective δ-agonists in post-weanling rats. Br J Pharmacol 107, 573-576.
8. Demirel HA, Powers SK, Zergeroglu MA, Shanely RA, Hamilton K, Coombes J & Naito H (2001). Short-term exercise improves myocardial tolerance to in vivo ischemia-reperfusion in the rat. J Appl Physiol 91, 2205-2212.
9. Denning GM, Ackermann LW, Barna TJ, Armstrong JG, Stoll LL, Weintraub NL & Dickson EW (2008). Proenkephalin expression and enkephalin release are widely observed in non-neuronal tissues. Peptides 29, 83-92.
10. Dickson EW, Hogrefe CP, Ludwig PS, Ackermann LW, Stoll LL & Denning GM (2008). Exercise enhances myocardial ischemic tolerance via an opioid receptor-dependent mechanism. Am J Physiol Heart Circ Physiol 294, H402-H408.
11. Dickson EW, Ludwig PS, Ackermann LW, Buresh CT & Denning GM (2006). Met5-enkephalin-Arg6-Phe7 (MEAP): a cardioprotective hormonal opioid. Acad Emerg Med 13, 813-819.
12. Frasier CR, Moore RL & Brown DA (2011). Exercise-induced cardiac preconditioning: how exercise protects your achy-breaky heart. J Appl Physiol 111, 905-915.
13. French JP, Hamilton KL, Quindry JC, Lee Y, Upchurch PA & Powers SK (2008). Exercise-induced protection against myocardial apoptosis and necrosis: MnSOD, calcium-handling proteins, and calpain. FASEB J 22, 2862-2871.
14. Gianoulakis C (2009). Endogenous opioids and addiction to alcohol and other drugs of abuse. Curr Top Med Chem 9, 999-1015.
15. ATP channels and myocardial preconditioning: an update. Am J Physiol Heart Circ Physiol 285, H921-H930.
16. Hamilton KL, Quindry J, French J, Lee Y & Powers SK (2005). MnSOD antisense oligonucleotide treatment attenuates exercise induced protection against infarction and apoptosis following ischemia-reperfusion. FASEB J 19, A709.
17. Hamilton KL, Quindry JC, French JP, Staib J, Hughes J, Mehta JL & Powers SK (2004). MnSOD antisense treatment and exercise-induced protection against arrhythmias. Free Radic Biol Med 37, 1360-1368.
18. Hamilton KL, Staib JL, Phillips T, Hess A, Lennon SL & Powers SK (2003). Exercise, antioxidants, and HSP72: protection against myocardial ischemia/reperfusion. Free Radic Biol Med 34, 800-809.
19. Handa K, Sasaki J, Tanaka H, Kiyonaga A, Matsunaga A, Shindo M & Arakawa K (1991). Effects of captopril on opioid peptides during exercise and quality of life in normal subjects. Am Heart J 122, 1389-1394.
20. Howells RD, Kilpatrick DL, Bailey LC, Noe M & Udenfriend S (1986). Proenkephalin mRNA in rat heart. Proc Natl Acad Sci USA 83, 1960-1963.
21. Huang MH, Nguyen V, Wu Y, Rastogi S, Lui CY, Birnbaum Y, Wang HQ, Ware DL, Chauhan M, Garg N, Poh KK, Ye L, Omar AR, Tan HC, Uretsky BF & Fujise K (2009). Reducing ischaemia/reperfusion injury through δ-opioid-regulated intrinsic cardiac adrenergic cells: adrenopeptidergic co-signalling. Cardiovasc Res 84, 452-460.
22. Kraemer WJ, Noble B, Culver B & Lewis RV (1985). Changes in plasma proenkephalin peptide F and catecholamine levels during graded exercise in men. Proc Natl Acad Sci USA 82, 6349-6351.
23. Lennon SL, Quindry JC, French JP, Kim S, Mehta JL & Powers SK (2004a). Exercise and myocardial tolerance to ischaemia-reperfusion. Acta Physiol Scand 182, 161-169.
24. Lennon SL, Quindry JC, Hamilton KL, French JP, Hughes J, Mehta JL & Powers SK (2004b). Elevated MnSOD is not required for exercise-induced cardioprotection against myocardial stunning. Am J Physiol Heart Circ Physiol 287, H975-H980.
25. Lennon SL, Quindry J, Hamilton KL, French J, Staib J, Mehta JL & Powers SK (2004c). Loss of exercise-induced cardioprotection after cessation of exercise. J Appl Physiol 96, 1299-1305.
26. ATP channels, and protein kinase C during cardiocyte apoptosis. J Mol Cell Cardiol 33, 2007-2014.
27. Locke M, Tanguay RM, Klabunde RE & Ianuzzo CD (1995). Enhanced postischemic myocardial recovery following exercise induction of HSP 72. Am J Physiol Heart Circ Physiol 269, H320-H325.
28. ATP channels and the autonomic nervous system. Life Sci 84, 657-663.
29. Michelsen MM, Støttrup NB, Schmidt MR, Løfgren B, Jensen RV, Tropak M, St-Michel EJ, Redington AN & Bøtker HE (2012). Exercise-induced cardioprotection is mediated by a bloodborne, transferable factor. Basic Res Cardiol 107, 260.
30. 99mTc sestamibi imaging predicts subsequent mortality. Circulation 92, 334-341.
31. O'Keefe JH, Patil HR, Lavie CJ, Magalski A, Vogel RA & McCullough PA (2012). Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc 87, 587-595.
32. Okubo S, Tanabe Y, Takeda K, Kitayama M, Kanemitsu S, Kukreja RC & Takekoshi N (2004). Ischemic preconditioning and morphine attenuate myocardial apoptosis and infarction after ischemia-reperfusion in rabbits: role of δ-opioid receptor. Am J Physiol Heart Circ Physiol 287, H1786-H1791.
33. ATP channel triggers opioid-induced delayed cardioprotection in the rat. Circ Res 91, 186-188.
34. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA & Braunwald E (1979). Myocardial infarct size and ventricular function in rats. Circ Res 44, 503-512.
35. Pfeffer MA, Pfeffer JM, Steinberg C & Finn P (1985). Survival after an experimental myocardial infarction: beneficial effects of long-term therapy with captopril. Circulation 72, 406-412.
36. Pierzchala K & VanLoon GR (1990). Plasma native and peptidase-derivable Met-enkephalin responses to restraint stress in rats. Adaptation to repeated restraint. J Clin Invest 85, 861-873.
37. Powers SK, Demirel HA, Vincent HK, Coombes JS, Naito H, Hamilton KL, Shanely RA & Jessup J (1998). Exercise training improves myocardial tolerance to in vivo ischemia-reperfusion in the rat. Am J Physiol Regul Integr Comp Physiol 275, R1468-R1477.
38. Powers SK, Sollanek KJ, Wiggs MP, Demirel HA & Smuder AJ (2014). Exercise-induced improvements in myocardial antioxidant capacity: the antioxidant players and cardioprotection. Free Radic Res 48, 43-51.
39. Quindry J, French J, Hamilton K, Lee Y, Mehta JL & Powers S (2005). Exercise training provides cardioprotection against ischemia-reperfusion induced apoptosis in young and old animals. Exp Gerontol 40, 416-425.
40. ATP channels, and exercise-induced cardioprotection against apoptosis. J Appl Physiol 113, 498-506.
41. ATP channel inhibition blunts arrhythmia protection in ischemic exercised hearts. Am J Physiol Heart Circ Physiol 299, H175-H183.
42. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, deSimone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND & Wylie-Rosett J (2011). Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 123, e18-e209.
43. Schultz JE & Gross GJ (2001). Opioids and cardioprotection. Pharmacol Ther 89, 123-137.
44. Schultz JJ, Hsu AK & Gross GJ (1997). Ischemic preconditioning and morphine-induced cardioprotection involve the delta (δ)-opioid receptor in the intact rat heart. J Mol Cell Cardiol 29, 2187-2195.
45. Sigg DC, Coles JA Jr, Oeltgen PR & Iaizzo PA (2002). Role of δ-opioid receptor agonists on infarct size reduction in swine. Am J Physiol Heart Circ Physiol 282, H1953-H1960.
46. Starnes JW, Taylor RP & Ciccolo JT (2005). Habitual low-intensity exercise does not protect against myocardial dysfunction after ischemia in rats. Eur J Cardiovasc Prev Rehabil 12, 169-174.
47. Sun SY, Liu Z, Li P & Ingenito AJ (1996). Central effects of opioid agonists and naloxone on blood pressure and heart rate in normotensive and hypertensive rats. Gen Pharmacol 27, 1187-1194.
48. Taylor RP, Harris MB & Starnes JW (1999). Acute exercise can improve cardioprotection without increasing heat shock protein content. Am J Physiol Heart Circ Physiol 276, H1098-H1102.
49. van den Brink OW, Delbridge LM, Rosenfeldt FL, Penny D, Esmore DS, Quick D, Kaye DM & Pepe S (2003). Endogenous cardiac opioids: enkephalins in adaptation and protection of the heart. Heart Lung Circ 12, 178-187.
50. Werns SW, Fantone JC, Ventura A & Lucchesi BR (1992). Myocardial glutathione depletion impairs recovery of isolated blood-perfused hearts after global ischaemia. J Mol Cell Cardiol 24, 1215-1220.
51. Yamashita N, Hoshida S, Otsu K, Asahi M, Kuzuya T & Hori M (1999). Exercise provides direct biphasic cardioprotection via manganese superoxide dismutase activation. J Exp Med 189, 1699-1706.